Related Experiment Video
Updated: May 28, 2025

Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
Reinforcing Nrf2 Signaling: Help in the Alzheimer's Disease Context
Annamaria la Torre1, Filomena Lo Vecchio1, Valentina Soccorsa Angelillis2
1Laboratory of Gerontology and Geriatrics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, 71013 Foggia, Italy.
Oxidative stress contributes to Alzheimer's disease (AD). Activating the Nrf2 pathway with natural compounds may offer neuroprotection and a novel therapeutic strategy for AD.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Oxidative stress is implicated in neurodegenerative diseases, notably Alzheimer's disease (AD), affecting the aging population.
- It is recognized as an early pathological marker in AD, coinciding with reduced free radical scavenging capacity in older adults.
- The Nrf2 transcription factor, crucial for antioxidant defenses, declines in both quantity and activity with age.
Purpose of the Study:
- To review natural compounds that activate the Nrf2 pathway for neuroprotection.
- To emphasize the role of Nrf2 signaling in combating oxidative stress and neurotoxicity.
- To explore a holistic approach for AD treatment and the development of Nrf2-targeting drugs.
Main Methods:
- Literature review of studies on Nrf2 pathway activation.
- Analysis of natural compounds with neuroprotective properties.
- Synthesis of information on oxidative stress mechanisms in AD.
Main Results:
- Nrf2 is a key regulator of antioxidant response.
- Natural compounds activating Nrf2 show neuroprotective effects.
- Aging impairs Nrf2 function, exacerbating AD pathology.
Conclusions:
- Nrf2 pathway activation is a promising strategy for AD prevention and treatment.
- Natural compounds offer a potential avenue for reinforcing antioxidant defenses in AD.
- Further research into Nrf2-targeting drugs is warranted for effective AD therapeutics.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Neural Regulation